The iPSC time-dependence paper generates ≥3 follow-on preprints/citations emphasizing patient heterogeneity within 12 weeks, changing zero clinical protocols.

A detailed new study using iPSCs (stem cells engineered from a patient's own blood or skin cells) is revealing exactly why some antidepressants work fast for some people but not others. Scientists will rush to build on it — expect at least three follow-up papers within three months. But none of this will change how any therapist or doctor actually treats patients yet. It's real progress, just very early-stage.

This is exactly the mechanistic granularity the field needs and rarely gets. It'll be amplified academically but is far upstream of clinical translation.